Riskpilot← Back to searchSign inGet full accessMedirista AB
ABActiveOrg 5567585715Karlbergsvägen 40Other human health activities n.e.c. · NACE 8699Est. 20080 employees
Revenue 2024
SEK 1,4M
+4% vs 2023
EBITDA margin
63.2%
+52% vs 2023
Equity ratio
-14.1%
Financial strength
Net profit 2024
SEK 1,1M
+260% vs 2023
| Revenue | SEK 1,4M | +4% |
| EBITDA | SEK 895K | +52% |
| Net profit | SEK 1,1M | +260% |
| Total assets | SEK 3,3M | +83% |
| Equity | SEK -463K | +70% |
| Employees | 0 | — |
Legal name
Medirista AB
Org number
5567585715
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
26 maj 2008
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva medicinsk rådgivning och läkarkonsultationer. Därtill litterär verksamhet och översättningsarbeten. Även fastighets- och värdepappershandel, dock ej sådan som kräver tillstånd enligt fondkomissionlagen.
Address
Karlbergsvägen 40
Phone
+46701104258
Email
anna.frostegard@medirista.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 183 | 382 | 786 | 1 360 | 1 416 |
| Staff expenses | — | — | — | — | −0 |
| EBITDA | 17 | 200 | 442 | 589 | 895 |
| Depreciation & amort. | −2 | −2 | −2 | −4 | −4 |
| EBIT | 15 | 198 | 440 | 585 | 891 |
| Net financials | — | −2 852 | −1 | −2 071 | −4 |
| Profit before tax | 15 | −1 228 | 339 | −607 | 1 097 |
| Tax | −0 | −0 | −90 | −80 | — |
| Net profit | 15 | −1 228 | 249 | −687 | 1 097 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 155 | 2 059 | 2 088 | 1 793 | 3 282 |
| Equity | 106 | −1 122 | −873 | −1 560 | −463 |
| Long-term debt | 0 | 3 086 | 2 292 | 2 916 | 3 118 |
| Short-term debt | 1 048 | 94 | 569 | 226 | 627 |
| Total debt | 1 048 | 3 180 | 2 861 | 3 142 | 3 745 |
EBITDA margin
63.2%
This company
15.8%
Market median
+300% vs market
20202024
Equity ratio
-14.1%
This company
38.2%
Market median
-137% vs market
20202024
Return on equity
109710500.0%
This company
18.4%
Market median
+596252617% vs market
20202024
Net profit margin
77.5%
This company
8.1%
Market median
+857% vs market
20202024
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20202024
Debt / equity
8.10×
This company
0.62×
Market median
-1206% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medirista AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Johan Frostegård | Board of Directors | 0 companies |
| Anna Frostegård | Board of Directors | 0 companies |